TrialHaematologica2012

High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial.

Andreas L Petzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.